Intelligence Profile
Clinical Applications
The available evidence for estradiol cypionate clinical applications is extremely limited in human medicine. Most of the provided research focuses on veterinary applications, particularly in cattle breeding and reproductive synchronization protocols.
Human Clinical Uses
Based on the sparse clinical trial evidence available:
Reproductive Medicine and Hormone Therapy:
- One phase 2 trial (NCT05143723) investigated luteal phase support combining estradiol with progesterone in IVF/ICSI cycles, though results are not provided
- A phase 3 study (NCT03981341) examined estrogen therapy effects on oxidative stress in post-menopausal women, but specific outcomes for estradiol cypionate are not detailed
- Research into endometrial response in polycystic ovarian syndrome when combined with letrozole is planned but not yet recruiting (NCT07379502)
Other Applications:
- Limited investigation into effects on circulating endothelial progenitor cells and HDL cholesterol in men (NCT00729859), though this appears to focus on cardiovascular rather than hormonal outcomes
Veterinary Applications
The majority of available evidence relates to cattle reproductive management, where estradiol cypionate is used in:
- Fixed-time artificial insemination (FTAI) protocols
- Ovulation synchronization programs
- Breeding efficiency improvement in dairy and beef cattle
Evidence Limitations
The clinical evidence for estradiol cypionate in human medicine is notably thin. Most studies either lack reported outcomes, are still in planning phases, or focus on veterinary applications. The paucity of robust human clinical data makes it difficult to draw definitive conclusions about therapeutic efficacy and safety profiles in clinical practice.
This information is for educational purposes only and does not constitute medical advice. Consult with a healthcare provider for personalized medical recommendations.